The Brandes U.S. Small-Mid Cap Value Equity Strategy seeks long-term capital appreciation by investing primarily in the equity securities of U.S. issuers with equity market capitalizations greater than $1.5 billion but no greater than $10 billion at the time of purchase.
Chris Duncan is a Director, Investments Group, a Senior Analyst on the Basic Materials Research Team and a member of the Small-Mid Cap Investment Committee. He is a limited partner of the firm’s parent company. Before joining the firm, Mr. Duncan was as an M&A Analyst with NCR Corporation. He earned his BS in finance from the University of Dayton and his MBA (with honors) from the University of Chicago Booth School of Business. Mr. Duncan’s relevant experience began in 2001 and he joined Brandes Investment Partners in 2006.
Michael Hutchens is a Director, Investments Group and a Senior Analyst on the Financial Institutions Research Team. He is a member of the Small-Mid Cap Investment Committee and the All-Cap Investment Committee. Mr. Hutchens is a limited partner of the firm’s parent company. Before joining Brandes, he was a Bank examiner with the Federal Reserve System. Mr. Hutchens earned his MBA with a concentration in finance from Columbia Business School and his BS in business with a concentration in finance from Indiana University. His experience began in 1994 and he joined Brandes Investment Partners in 2001.
Greg Rippel is a Director, Investments Group, an Analyst on the Consumer Products Research Team and a member of the Small-Mid Cap Investment Committee. Previously, he was a member of the Emerging Markets Investment Committee. Before joining the firm, Mr. Rippel was an Underwriter with Greyrock Capital (a subsidiary of Bank of America) and a Senior Associate with Coopers & Lybrand. He holds an MBA from the McCombs School of Business at the University of Texas at Austin, a BA in business economics from the University of California, Santa Barbara and is a Certified Public Accountant (inactive). His relevant experience began in 1995 and he joined Brandes Investment Partners in 2001.
As of 31 Mar 2025 | Reporting Currency: EUR
Data displayed as of 30 Jun 2025
| Characteristic | U.S. Small-Mid Cap Value Equity | Russell 2500 Index |
|---|---|---|
|
Price/Book (x)
Price per share divided by book value per share.
|
1.5 | 2.3 |
|
Price/Earnings (x)
Price per share divided by earnings per share.
|
14.7 | 19.6 |
|
Price/Cash Flow (x)
Price per share divided by cash flow per share.
|
8.1 | 10.5 |
|
Dividend Yield %
Dividends per share divided by price per share.
|
1.9 | 1.5 |
|
Active Share %
A measure of the percentage of stock holdings in a manager’s portfolio that differs from the benchmark index.
|
96.5 | -- |
| Number of Holdings | 66 | -- |
| Weighted Average Mkt. Cap (€bil) | 6.1 | 6.0 |
|
Portfolio Turnover (TTM) %
(Trailing Twelve Months)
|
23.2 | -- |
| Company | % | Country | Industry |
|---|---|---|---|
| Premier Inc | 3.3 | United States | Health Care Providers & Services |
| NETGEAR Inc | 3.1 | United States | Communications Equipment |
| Amdocs Ltd | 3.1 | United States | IT Services |
| IPG Photonics Corp | 2.8 | United States | Electronic Equipment, Instruments & Components |
| Embraer SA | 2.8 | Brazil | Aerospace & Defense |
| National Presto Industries Inc | 2.4 | United States | Aerospace & Defense |
| Arlo Technologies Inc | 2.3 | United States | Electronic Equipment, Instruments & Components |
| Edgewell Personal Care Co | 2.3 | United States | Personal Care Products |
| Ingles Markets Inc | 2.2 | United States | Consumer Staples Distribution & Retail |
| Elanco Animal Health Inc | 2.1 | United States | Pharmaceuticals |
| % of Portfolio | 26.4 | ||
| Portfolio holdings are subject to change at any time at the discretion of the investment manager. | |||
The portfolio characteristics shown relate to a single account deemed by Brandes to be generally representative of the strategy as of date noted. Not every account will have these exact characteristics. The actual characteristics with respect to any particular account will vary based on a number of factors including but not limited to: (i) the size of t he account; (ii) investment restrictions applicable to the account, if any; and (iii) market exigencies at the time of investment. Characteristics identified are calculated on a gross basis without the deduction of fees and expenses. Data is updated on a quarterly basis.
Market Capitalization, Price/Book, Price/Earnings, Price/Cash Flow, and Dividend Yield for each security provided by Bloomberg, L.P. Please note that Bloomberg does not provide negative numbers in the data feed. Index fundamentals are calculated from holdings data as provided by the relevant index or by FactSet Fundamentals, excluding negative numbers for consistency. Thus, index fundamentals calculated by Brandes may differ from those computed and published by index providers.
The Russell 2500 with gross dividends measures the performance of the small to mid cap segment of the U.S. equity universe. The benchmark returns are not covered by the report of independent verifiers.
The Russell 2500 Value Index with gross dividends measures the performance of the small to mid cap segment of the U.S. equity universe. Securities are categorized as growth or value based on their relative book to price ratios, historical sales growth, and expected earnings growth.